Implantable Cardioverter Defibrillators May Fail to Deliver Therapy
Medtronic implantable defibrillators with certain feedthroughs may fail to deliver high-voltage therapy when needed. This rare malfunction could prevent life-saving electrical treatment.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This product received an FDA Class I classification, which mandates a minimum severity score of 4. The potential for reduced or absent electrical output in a life-critical implanted cardiac device represents a serious patient safety risk.
Plain-English summary
Medtronic Inc. is recalling 425 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), model DVAB1D1 VISIA AF, due to a manufacturing defect.
The recalled devices contain a specific type of feedthrough that may result in reduced or no electrical output during high-voltage therapy, typically 0-12J. This rare potential malfunction could prevent the device from delivering necessary therapy.
The affected devices were distributed nationwide and worldwide. Specific lot serial numbers are documented in the recall notice.
The recalled product
- Product
- ICD-VR DVAB1D1 VISIA AF US IS1/DF1, Model Number DVAB1D1; Implantable Cardioverter Defibrillators
- Affected units
- 425
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- GTIN 00643169720619
- Lot Serial Numbers: BWN203363H
- BWN203588H
- BWN203428H
- BWN203504H
- BWN203530H
- BWN203214H
- BWN203258H
- BWN203259H
- BWN203304H
- BWN203477H
- BWN203665H
- BWN203423H
- BWN203403H
- BWN203327H
- BWN203518H
- BWN203790H
- BWN203174H
- BWN203624H
- BWN203750H
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 120 recalled by Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 120 products in this recall →Related recalls
Same manufacturer · Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
See all →- CriticalMedtronic CRT-D Defibrillators: Rare Energy Output Failure Risk During Therapy
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillators Recalled for Reduced Therapy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Defibrillators Recalled for Potential Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators at Risk of Reduced Energy Output
FDA (Devices) · 2023-06-28
- SevereMedtronic Implantable Cardioverter Defibrillator may lose energy output during therapy
FDA (Devices) · 2023-06-28
Same hazard · therapy delivery failure
See all →- HighPhysio-Control Defibrillators May Lack Required Performance Inspection
FDA (Devices) · 2026-05-13
- SevereMedtronic Implantable Cardiac Defibrillators Risk Therapy Delivery Failure
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators With Defective Feedthrough May Fail to Deliver Therapy
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators Risk Therapy Failure Due to Feedthrough Defect
FDA (Devices) · 2023-06-28
- CriticalImplantable Cardioverter Defibrillators Recalled for Potential High-Voltage Therapy Failure
FDA (Devices) · 2023-06-28